-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KCtIUxHyxd5M1eyfsylCo/lNIDDhQEx/CE+dNhgXSPkBBqp6NWUpaKZ0vE3W4nNM BaqvrzFlmhNYHtk1U9GRqw== 0000950124-06-005602.txt : 20060928 0000950124-06-005602.hdr.sgml : 20060928 20060928162716 ACCESSION NUMBER: 0000950124-06-005602 CONFORMED SUBMISSION TYPE: 8-A12B PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060928 DATE AS OF CHANGE: 20060928 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trubion Pharmaceuticals, Inc CENTRAL INDEX KEY: 0001298521 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 8-A12B SEC ACT: 1934 Act SEC FILE NUMBER: 001-33054 FILM NUMBER: 061114276 BUSINESS ADDRESS: STREET 1: 2401 14TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2068380500 MAIL ADDRESS: STREET 1: 2401 14TH AVENUE STREET 2: SUITE 1050 CITY: SEATTLE STATE: WA ZIP: 98121 8-A12B 1 v23950e8va12b.htm FORM 8-A12B e8va12b
 

 
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-A
 
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Trubion Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
 
     
Delaware   52-2385898
(State of incorporation or organization)   (I.R.S. Employer Identification No.)
     
2401 4th Avenue, Suite 1050    
Seattle, Washington   98104
(Address of principal executive offices)   (Zip Code)
     If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. þ
     If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. o
     Securities Act registration statement file number to which this form relates: 333-134709
Securities to be registered pursuant to Section 12(b) of the Act:
     
Title of each class
to be so registered 		  Name of each exchange on which
each class is to be registered
     
Common Stock, par value $0.001 per share   The NASDAQ Global Market
Securities to be registered pursuant to Section 12(g) of the Act:
None
(Title of Class)
 
 

 

 

Item 1. Description of Registrant’s Securities to be Registered
Trubion Pharmaceuticals, Inc. (the “Registrant”) incorporates by reference the description of its securities to be registered hereunder contained under the heading “Description of Capital Stock” as set forth in the Registrant’s Registration Statement on Form S-1, as filed with the Commission on June 2, 2006, as amended (File Number 333-134709), and including any subsequent amendments thereto, including the Registrant’s prospectus to be filed pursuant to Rule 424(b) under the Securities Act which is hereby deemed to be incorporated by reference in response to this item.
Item 2. Exhibits
The following exhibits are filed as a part of this registration statement:
         
 
  3.1*   Form of Amended and Restated Certificate of Incorporation of the registrant to be in effect after the completion of the registrant’s initial public offering of shares of its common stock pursuant to the Registration Statement on Form S-1.
 
        
 
  3.2*   Form of Amended and Restated Bylaws of the registrant to be in effect upon consummation of the registrant’s initial public offering of shares of its common stock pursuant to the Registration Statement on Form S-1.
 
        
 
  4.1*   Form of registrant’s common stock certificate.
 
        
 
  4.2*   Amended and Restated Investors’ Rights Agreement dated July 13, 2004.
 
*   Incorporated by reference to exhibits of the same number on the Registrant’s Registration Statement on Form S-1, as filed with the Commission on June 2, 2006 (File No. 333-134709).

 

 

SIGNATURE
     Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
         
Date: September 28, 2006  TRUBION PHARMACEUTICALS, INC.
 		  
  By:   /s/ Michelle Burris    
    Michelle Burris   
    Senior Vice President and Chief
Financial Officer 		  
 

 

-----END PRIVACY-ENHANCED MESSAGE-----